Kidney Disease Clinical Trials in Dallas, Texas
24 recruitingDallas, Texas
Showing 1–20 of 24 trials
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled759 locationsNCT06742723
Recruiting
Phase 3
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Chronic Kidney Disease
Boehringer Ingelheim120 enrolled102 locationsNCT07107945
Recruiting
Phase 2
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Regeneron Pharmaceuticals270 enrolled47 locationsNCT07271186
Recruiting
Phase 2
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Maze Therapeutics56 enrolled81 locationsNCT06830629
Recruiting
Phase 2
Ferric Citrate and Chronic Kidney Disease in Children
Chronic Kidney Diseases
University of California, Los Angeles160 enrolled20 locationsNCT04741646
Recruiting
Kidney Precision Medicine Project
Chronic Kidney DiseasesType 1 Diabetes (T1D)Kidney Failure, Acute+12 more
Icahn School of Medicine at Mount Sinai1,000 enrolled13 locationsNCT04334707
Recruiting
Not Applicable
SPYRAL GEMINI Pilot Study
Diabetes MellitusCardiovascular DiseasesHypertension+2 more
Medtronic Vascular175 enrolled13 locationsNCT06907147
Recruiting
Sickle Cell Kidney Biorepository
Chronic Kidney DiseaseSickle Cell TraitSickle Cell Disease (SCD)
University of Texas Southwestern Medical Center800 enrolled2 locationsNCT07064174
Recruiting
Phase 2
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities
Proteinuric Kidney Disease
Vertex Pharmaceuticals Incorporated45 enrolled35 locationsNCT06794996
Recruiting
Not Applicable
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Kidney Disease, End-Stage
C. R. Bard280 enrolled17 locationsNCT04634916
Recruiting
Phase 3
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Chronic Kidney DiseaseSecondary Hyperparathyroidism
Amgen56 enrolled43 locationsNCT03633708
Recruiting
Phase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Not Applicable
Phosphate Assessment in Chronic Kidney Disease Patients Study
Chronic Kidney Disease (Stage 3-4)
University of Texas Southwestern Medical Center60 enrolled1 locationNCT07368946
Recruiting
Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
Chronic Kidney DiseasesEnd Stage Kidney Disease (ESRD)Major Depressive Disorder
Stony Brook University201 enrolled4 locationsNCT04422652
Recruiting
Not Applicable
Diuretic Tuner Clinical Decision Support
EdemaChronic Kidney DiseasesHypervolemia+1 more
University of Texas Southwestern Medical Center30 enrolled1 locationNCT04759274
Recruiting
Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
Chronic Kidney Diseases
The University of Texas at Arlington28 enrolled2 locationsNCT03471117
Recruiting
Phase 4
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
Chronic Kidney Disease
The University of Texas at Arlington15 enrolled2 locationsNCT03982160
Recruiting
Not Applicable
Amnioinfusion for Fetal Renal Failure
Polycystic Kidney DiseaseMulticystic Dysplastic KidneyFetal Renal Anomaly+6 more
Fetal Care Center, PLLC35 enrolled1 locationNCT06728228
Recruiting
Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake
Chronic Kidney Disease
Scaled Insights3,000 enrolled1 locationNCT06533254
Recruiting
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
Kidney DiseasesTransplant
Methodist Health System240 enrolled1 locationNCT04182607